Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12000056
[patent_doc_number] => 20170304212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'GENE CARRIER USING CELL-DERIVED NANOVESICLES AND METHOD FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/495395
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6505
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495395 | Gene carrier using cell-derived nanovesicles and method for preparing the same | Apr 23, 2017 | Issued |
Array
(
[id] => 17769598
[patent_doc_number] => 11401527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Compositions and methods useful for prophylaxis of organophosphates
[patent_app_type] => utility
[patent_app_number] => 16/093411
[patent_app_country] => US
[patent_app_date] => 2017-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 41
[patent_no_of_words] => 18679
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093411 | Compositions and methods useful for prophylaxis of organophosphates | Apr 14, 2017 | Issued |
Array
(
[id] => 14016635
[patent_doc_number] => 20190070311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II
[patent_app_type] => utility
[patent_app_number] => 16/093413
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093413 | Gene therapy for treating mucopolysaccharidosis type II | Apr 13, 2017 | Issued |
Array
(
[id] => 11935222
[patent_doc_number] => 20170239371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/482117
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19043
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/482117 | Lipid nanoparticle compositions and methods for MRNA delivery | Apr 6, 2017 | Issued |
Array
(
[id] => 16277044
[patent_doc_number] => 10760061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA
[patent_app_type] => utility
[patent_app_number] => 15/479979
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 10041
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479979 | Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA | Apr 4, 2017 | Issued |
Array
(
[id] => 13263379
[patent_doc_number] => 10143759
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-12-04
[patent_title] => Method for the treatment of malignancies
[patent_app_type] => utility
[patent_app_number] => 15/477783
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 11933
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477783 | Method for the treatment of malignancies | Apr 2, 2017 | Issued |
Array
(
[id] => 14069333
[patent_doc_number] => 20190083554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS OF HEAT INACTIVATION OF ADENOVIRUS
[patent_app_type] => utility
[patent_app_number] => 16/085177
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085177 | Methods of heat inactivation of adenovirus | Mar 27, 2017 | Issued |
Array
(
[id] => 14758293
[patent_doc_number] => 10390521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Parkinsons disease model and methods
[patent_app_type] => utility
[patent_app_number] => 15/464047
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 54
[patent_no_of_words] => 23727
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464047
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464047 | Parkinsons disease model and methods | Mar 19, 2017 | Issued |
Array
(
[id] => 14067579
[patent_doc_number] => 20190082677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => A SURFACE TENSION MEDIATED LYO-PROCESSING TECHNIQUE FOR PRESERVATION OF BIOLOGICS
[patent_app_type] => utility
[patent_app_number] => 16/085379
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085379 | Surface tension mediated lyo-processing technique for preservation of biologics | Mar 13, 2017 | Issued |
Array
(
[id] => 17741519
[patent_doc_number] => 11389566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method and composition for treating inflammatory bowel disease
[patent_app_type] => utility
[patent_app_number] => 16/085001
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12923
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085001
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085001 | Method and composition for treating inflammatory bowel disease | Mar 13, 2017 | Issued |
Array
(
[id] => 11744214
[patent_doc_number] => 20170198286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus Thermophilus'
[patent_app_type] => utility
[patent_app_number] => 15/448818
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 19246
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448818 | Programmable RNA shredding by the type III-A CRISPR-Cas system of | Mar 2, 2017 | Issued |
Array
(
[id] => 16428275
[patent_doc_number] => 10828336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Cell-based therapy for the pulmonary system
[patent_app_type] => utility
[patent_app_number] => 15/443789
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 26737
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443789
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443789 | Cell-based therapy for the pulmonary system | Feb 26, 2017 | Issued |
Array
(
[id] => 13287713
[patent_doc_number] => 10155029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Terminally modified RNA
[patent_app_type] => utility
[patent_app_number] => 15/429532
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 149662
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429532 | Terminally modified RNA | Feb 9, 2017 | Issued |
Array
(
[id] => 14182895
[patent_doc_number] => 20190111152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => FUNCTIONALIZED METAL NANOPARTICLE
[patent_app_type] => utility
[patent_app_number] => 16/073296
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073296 | Functionalized metal nanoparticle | Jan 26, 2017 | Issued |
Array
(
[id] => 16893398
[patent_doc_number] => 11034933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection
[patent_app_type] => utility
[patent_app_number] => 16/070745
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 10726
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070745 | Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection | Jan 26, 2017 | Issued |
Array
(
[id] => 16925469
[patent_doc_number] => 11046932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Method of producing renal cells from differentiated cells
[patent_app_type] => utility
[patent_app_number] => 16/072459
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 21
[patent_no_of_words] => 15230
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072459 | Method of producing renal cells from differentiated cells | Jan 24, 2017 | Issued |
Array
(
[id] => 17060285
[patent_doc_number] => 11104875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Linked perfusion to continuous-flow stirred-tank reactor cell culture system
[patent_app_type] => utility
[patent_app_number] => 16/071941
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16844
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071941
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071941 | Linked perfusion to continuous-flow stirred-tank reactor cell culture system | Jan 24, 2017 | Issued |
Array
(
[id] => 13871299
[patent_doc_number] => 20190031990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHOD FOR DISSOCIATING CELL AGGREGATES
[patent_app_type] => utility
[patent_app_number] => 16/072379
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072379 | Method for dissociating cell aggregates | Jan 24, 2017 | Issued |
Array
(
[id] => 11618308
[patent_doc_number] => 20170128495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'Method of Correcting Pathological Human Skin Conditions Related to Aging'
[patent_app_type] => utility
[patent_app_number] => 15/412467
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10009
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412467
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412467 | Method of Correcting Pathological Human Skin Conditions Related to Aging | Jan 22, 2017 | Abandoned |
Array
(
[id] => 11744184
[patent_doc_number] => 20170198256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'ENCAPSULATION AND CARDIAC DIFFERENTIATION OF hiPSCs IN 3D PEG-FIBRINOGEN HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 15/411807
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15751
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411807
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411807 | Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels | Jan 19, 2017 | Issued |